Kenya Artificial Intelligence (AI) in Healthcare Market Analysis Sample Report

1. A sample report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2022 – 2030F) www.insights10.com

2. This report presents a strategic analysis of the Kenya Artificial Intelligence (AI) in Healthcare Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, types of clinical diagnostics, point-of-care testing, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Kenya Artificial Intelligence (AI) in Healthcare Market, and offers unmatched value, accuracy, and expert insights

3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

4. Table of Content CONTENT PG. NO. 12-25 1. Artificial Intelligence (AI) in Healthcare Overview 1.1. Overview 1.2. Kenya Overview 1.3. Economic Overview: Kenya 1.4. Artificial Intelligence (AI) in Healthcare Market in Kenya 1.5. Digital Health Market in Kenya 1.6. Healthcare Scenario in Kenya 1.7. Health Insurance Coverage: Kenya 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 26-33 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 4 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

5. Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. Healthcare Component 2.2.2. Healthcare Applications 34-38 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. Kenya Artificial Intelligence (AI) in Healthcare Market Driver 1 3.1.2. Kenya Artificial Intelligence (AI) in Healthcare Market Driver 2 3.1.3. Kenya Artificial Intelligence (AI) in Healthcare Market Driver 3 3.2. Market Restraints 3.2.1. Kenya Artificial Intelligence (AI) in Healthcare Market Restraint 1 3.2.2. Kenya Artificial Intelligence (AI) in Healthcare Market Restraint 2 5 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

6. Table of Content CONTENT PG. NO. 3.2.3. Kenya Artificial Intelligence (AI) in Healthcare Market Restraint 3 39-49 4. Competitive Landscape 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. Merative 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 4.2.2. NVIDIA 4.2.2.1. Overview 6 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

7. Table of Content CONTENT PG. NO. 4.2.2.2. Product Applications & Services 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. Google Health 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 4.2.4. CloudMedX 4.2.4.1. Overview 7 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

8. Table of Content CONTENT PG. NO. 4.2.4.2. Product Applications & Services 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. Corti 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 4.2.6. M-Tiba 4.2.6.1. Overview 8 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

9. Table of Content CONTENT PG. NO. 4.2.6.2. Product Applications & Services 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. Ilara Health 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 4.2.8. DeepMind 4.2.8.1. Overview 9 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

10. Table of Content CONTENT PG. NO. 4.2.8.2. Product Applications & Services 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. Komodo 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 4.2.10. Oncora Medical 4.2.10.1. Overview 10 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

11. Table of Content CONTENT PG. NO. 4.2.10.2. Product Applications & Services 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 50-57 5. Reimbursement Scenario 5.1. Reimbursement Regulation 5.2. Reimbursement Process for Diagnosis 5.3. Reimbursement Process for Treatment 58-63 6. Methodology & Scope 11 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

12. Kenya Artificial Intelligence (AI) in Healthcare Market Analysis 1. Artificial Intelligence (AI) in Healthcare Overview

13. 1.1 Statistics at a Glance: The Scenario of AI in healthcare in the World Scope of AI in healthcare Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ $120 Bn AI is worth in the global market $1.5 Tn AI will be worth by $1.5 Tn by 2030 In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 35% of businesses use AI on a daily basis 83% of healthcare organizations have implemented an AI strategy In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 15% of healthcare organizations are planning to develop AI in their solutions 59% of the leaders believe that AI will lead to significant cost savings according to a survey 13 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

14. 1.1 Statistics at a Glance: The Scenario of Artificial Intelligence (AI) in Healthcare in the World (continued) Europe ~Revenue to reach $XX Bn by 2027 North America ~ Market Size of $XX Bn Asia -Fastest CAGR Africa Egypt Market ~$XX Mn Market ~Market Size of $XX Bn Illustrative Illustrative 14 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

15. 1.2 Kenya Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 53 Mn Is the population of Kenya, in 2021 $110 Bn Is the Gross Domestic Product (GDP) in Kenya in 2021 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 20 Is the median age in Kenya, in 2021 $83.4 per capita was the amount of national health expenditures in 2021 15 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

16. 1.3 Economic Overview: Kenya Population of Kenya, (2020-2030) GDP of Kenya, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 16 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

17. 1.4 Statistics at a Glance: The Scenario of AI in Healthcare in Kenya Scope of AI in Healthcare Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 49 applications of AI are currently in use in Kenya 4 out of 10 Kenya features at number 4 within the top 10 African countries ranked on the Government AI Readiness index In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Kenya ▪ 7,000 facilities in Kenya has implemented AI for medical supplies 50% AI has improved the availability of medical supplies by 50% in Kenya In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 100,000 photos of cervical tissues are identified with the help of AI for the detection of cancer in Kenya $130 Mn Kenya has spent $130 Mn in the last 10 years for the adoption of AI Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 17 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

18. 1.5 Digital Health in Kenya Kenya Digital Health Market Forecast, 2022-2030 (in $Bn) XX 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Digital Health market in Kenya, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 18 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

19. 1.6 Healthcare Scenario in Kenya Artificial Intelligence (AI) in Healthcare Drug Development Process: The process of developing a Artificial Intelligence (AI) in Healthcare drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the Artificial Intelligence (AI) in Healthcare drug development process: Preclinical Research: Researchers identify potential drug candidates and test them in the lab Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating Artificial Intelligence (AI) in Healthcare Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market o o o o o FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need ▪ Fast Track A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Breakthrough Therapy ▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved based on a surrogate endpoint Accelerated Approval ▪ Priority Review A Priority Review designation means FDA’s goal is to take action on an application within 6 months ▪ Illustrative Illustrative 19 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

20. 1.6 Healthcare Scenario: Patient Journey Presentation Diagnosis Treatment Follow up Confirmatory Diagnosis Complete blood count (evaluate number & quality of RBCs, Hb & WBCs) Prevention and management of crisis: • For VOC and Splenic Sequestration: HU, Endari, Adakveo, Oxbryta • For infections: Antibiotics, Vaccines • Long term follow-up is required for patients with SCD • Annual assessment: CBC and reticulocyte count, iron status, liver and renal function tests, urinalysis, LDH, vitamin D level and neurocognitive assessment • ESOD (End Stage Organ Damage) evaluation starting from age 7 • Yearly Transcranial Doppler test to determine risk of stroke Initial Diagnosis Imaging (confirm bone related changes or respiratory problems) A suspected diagnosis is usually made, based on physical examination and detailed patient and family history Prenatal screening/ Neonatal screening Bacterial cultures of blood, sputum, urine, stool (detect any infection) Prevention and management of complications: Genetic testing (detect the type of SCD) • Stroke: Chronic transfusions, HU Stakeholders PCP, pediatrician, neonatologist, endocrinologist, cardiologist, hematologist, orthopedist, psychologist and psychiatrist PCP, paediatrician, neonatologist, haematologist and genetic counsellor PCP, pediatrician, medical geneticist, cardiologist, hematologist, endocrinologist, psychologist and psychiatrist PCP, pediatrician, medical geneticist, hematologist, gynecologist and pathologist Depending on the organ complications, the treatment involves different specialists at different times Illustrative Illustrative 20 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

21. 1.7 Health Insurance Coverage: Kenya % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare Medicaid 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 21 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

22. 1.8 Budget of Kenya Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicare In Billions Of Dollars $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 Medicaid 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicare As % Of GDP 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% Medicaid National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% oftotal NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 22 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

23. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 23 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

24. 1.9 Mergers and Acquisitions (continued) Latest Deals In Kenya Amount / Duration Company Name Type Year Key Pointers Oracle’s acquisition of Cerner is big tech’s latest foray into the healthcare system, promising better outcomes Oracle acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 Bn in equity value Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities ▪ ▪ Acquisition $28.3 Bn June, 2022 ▪ Oracle acquisition of Cerner GSK has acquire BELLUS for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion ▪ BELLUS is a late-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough ▪ Acquisition $2 Bn April 2023 Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough ▪ GSK acquisition of BELLUS Health Illustrative Illustrative 24 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

25. 1.9 Mergers and Acquisitions (continued) Latest Deals In Kenya Amount / Duration Company Name Type Year Key Pointers Merger March 2023 Merger Jan 2023 25 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

26. Kenya Artificial Intelligence (AI) in Healthcare Market Analysis 2. Market Size and Forecasting

27. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Kenya Artificial Intelligence (AI) in Healthcare Market Forecast, 2022- 2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Kenya Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ % of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Kenya Market Size (Bn $) 61 74 84 87 91 95 99 106 27 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

28. 2.2 Snapshot of Artificial Intelligence in Healthcare Market Segmentation • Software Solutions • Hardware • Services Healthcare Component • Robotic Assisted Surgery • Virtual Assistants • Administrative Workflow Assistants • Connected Machines • Diagnosis • Clinical Trials • Fraud Detection • Cybersecurity • Dosage Error Reduction Healthcare Applications In this section you will get an understanding of the segmentations which will cover the Kenya Artificial Intelligence (AI) in Healthcare Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 28 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

29. 2.2.1 Market Segmentation: By Healthcare Component Software solutions market in Kenya is a significant component of the overall Artificial Intelligence (AI) in the healthcare treatment market ▪ Kenya Artificial Intelligence (AI) in Healthcare Market Share, By Healthcare Component (2022) It has the maximum market share in Kenya Artificial Intelligence (AI) in the healthcare market with approximately xx% ▪ Services Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Software Solutions In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Hardware Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 29 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

30. 2.2.2 Market Segmentation: By Healthcare Applications Blood Artificial Intelligence (AI) in Healthcare market in Kenya is a significant component of the overall Artificial Intelligence (AI) in Healthcare market ▪ Kenya Artificial Intelligence (AI) in Healthcare Market Share, By Healthcare Applications (2022) Dosage Error Reduction Cybersecurity Fraud Detection It has the maximum market share in Kenya Artificial Intelligence (AI) in Healthcare market with approximately 42% ▪ Robot-Assisted Suregery Clinical Trials Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Diagnosis In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Connected Machines Virtual Assistants Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Administrative Workflow Assistants 30 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

31. Kenya Artificial Intelligence (AI) in Healthcare Market Analysis 3. Market Dynamics

32. 3.1 Market growth drivers 3.1.1 Incidence of Artificial Intelligence (AI) in Healthcare is increasing in Kenya, with more than 1.8 Mn new Artificial Intelligence (AI) in Healthcare cases expected to be diagnosed in 2023 Incidence of Artificial Intelligence (AI) in Healthcare in Kenya Incidence of Artificial Intelligence (AI) in Healthcare is increasing in Kenya, with more than 1.8 Mn new Artificial Intelligence (AI) in Healthcare cases expected to be diagnosed in 2023 ▪ This is driving the demand for Artificial Intelligence (AI) in Healthcare treatments and creating opportunities for growth in the Artificial Intelligence (AI) in Healthcare market ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 32 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

33. 3.1 Market growth drivers (continued) 3.1.2 Death rate from Artificial Intelligence (AI) in Healthcare in Kenya has declined by 31% from 1992 to 2022, largely due to advances in technology and treatment options Top countries that are leveraging technology in their fight against Artificial Intelligence (AI) in Healthcare Kenya has a long history of investing in Artificial Intelligence (AI) in Healthcare research and treatment, and as a result, has become a world leader in the field ▪ Norway IT has a robust healthcare infrastructure, including world- renowned research institutions, hospitals, and clinics, that are dedicated to Artificial Intelligence (AI) in Healthcare treatment and research ▪ Austria Denmark Belgium Spain Italy Netherlands One of the key factors that has allowed Kenya to stay ahead in the field of Artificial Intelligence (AI) in Healthcare research and treatment is the high level of investment in Artificial Intelligence (AI) in Healthcare-related research ▪ Sweden Singapore Switzerland Israel Australia In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Canada France United Kingdom Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ China South Korea Germany Japan United States Illustrative Illustrative 33 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

34. 3.1 Market growth drivers (continued) 3.1.3 In 2021, the National Artificial Intelligence (AI) in Healthcare Institute (NCI) received $6.4 Bn in funding from Kenya federal government to support Artificial Intelligence (AI) in Healthcare research and training programs Fundings from government and other organizations Kenya government provides significant support and funding for Artificial Intelligence (AI) in Healthcare research and treatment, which is driving innovation and growth in the Artificial Intelligence (AI) in Healthcare market ▪ Source Year Fund ($) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ National Artificial Intelligence (AI) in Healthcare Institute (NCI) 2021 $ 6.4 Bn In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Centers for Disease Control and Prevention (CDC) 2021 $ 501 Mn Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ American Artificial Intelligence (AI) in Healthcare Society (ACS) 2020 $ 150 Mn Susan G. Komen 2020 $ 98 Mn Illustrative Illustrative 34 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

35. 3.2 Market restraints 3.2.1 In 2020, the average cost of a new AI in Healthcare drug was over $150,000 per year 3.2.2 Average cost of developing a new AI in healthcare drug that is ultimately approved by the FDA is over $2.6 Bn 3.2.3 Demand for AI in healthcare care is expected to increase by 42% by 2025, while the supply of oncologists is only expected to increase by 28% AI in healthcare treatments can be very expensive and can lead to financial burden for patients and healthcare systems Cost of AI in healthcare treatment varies depending on the type of AI, stage of AI in healthcare, and treatment options Some common AI in healthcare treatments, such as chemotherapy and radiation therapy, can cost tens of thousands of dollars Regulatory requirements for AI in healthcare treatments can be very stringent, which can slow down the approval process and limit access to new treatments Regulatory bodies, such as Kenya Food and Drug Administration (FDA), require extensive clinical trials and safety data before approving new AI in healthcare treatments This can be a lengthy and costly process, which can delay the availability of new treatments for patients There is a shortage of oncologists in Kenya, which can limit access to AI in healthcare treatments and create barriers to growth in AI in healthcare market Oncologists are physicians who specialize in the diagnosis and treatment of AI in Healthcare With the aging population and the increasing incidence of AI in healthcare, there is a growing demand for oncologists However, the supply of oncologists is not keeping pace with the demand ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 35 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

36. Kenya Artificial Intelligence (AI) in Healthcare Market Analysis 4. Competitive Landscape

37. 4.1 Major Market Share Revenue of Major players in Kenya Artificial Intelligence (AI) in Healthcare Market ($ Mn) Kenya Artificial Intelligence (AI) in Healthcare market is a highly competitive space, with many companies developing and marketing Artificial Intelligence (AI) in Healthcare treatments ▪ Other Some of the top companies in Kenya Artificial Intelligence (AI) in Healthcare market based on revenue and market share include ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ XX Illustrative Illustrative 37 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

38. 4.2 Key Company Profile Key Note: 1 Merative Here is the list of top 10 companies which will cover in the final report ▪ 2 NVIDIA Each company will have slides for ▪ 3 Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Google Health o o 4 CloudMedX o o 5 Corti o 6 o M-Tiba o 7 Ilara Health o 8 DeepMind ▪ 9 Komodo ▪ 10 Oncora Medical 38 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

39. 4.2.1 Merative Solutions offered by Merative Founded in: 2022 ▪ Merative, previously IBM Watson Health, became an independent firm in 2022 ▪ Merative provides products and services that leverage artificial intelligence to assist clients in facilitating medical research, clinical research, real-world evidence, and healthcare services ▪ Francisco Partners, an American private equity firm based in San Francisco, California, owns Merative ➢ Clinical Decision Support HQ: Michigan, US ➢ Clinical Development Type: Private ➢ Enterprise Imaging Revenue: $168 Mn ➢ Healthcare Analytics Website: www.merative.com ➢ Health And Human Services Recent Activity / Press Coverage Merative wins three Best in KLAS Awards in 2023. Merge Cardio, Merge Hemo, and Micromedex® were each named Best in KLAS for cardiology, cardiology hemodynamics, and clinical decision support: point-of-care clinical reference Zelta is the new term for Merative Clinical Development. Merative's clinical trials solutions division, Zelta, comprises a clinical data management and acquisition platform as well as consulting, enablement, and extension services Francisco Partners Completes Acquisition of IBM's Healthcare Data and Analytics Assets 39 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

40. 4.2.1 Merative (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners One of the largest pharmaceutical distributors in the United States, McKesson has been a long-standing distribution partner for Merative Merative has been working with SAP, a leading software company, to develop digital solutions for its healthcare products A leading Swiss biotechnology company, Lonza provides Merative with contract manufacturing services for the production of its biologics and pharmaceuticals Cardinal Health is a Fortune 500 healthcare services company that provides pharmaceutical distribution services to Merative It is one of the largest drugstore chains in the United States and Europe, and its extensive network of retail locations and distribution centers make it an important distribution partner for Merative Merative has a strategic partnership with Microsoft to leverage its cloud computing and AI technologies in the development of new healthcare products Thermo Fisher Scientific is a leading provider of analytical instruments, reagents, and laboratory services A leading healthcare services provider in Asia, Zuellig Pharma is a distribution partner for Merative in several Asian countries GE Healthcare provides Merative with advanced medical imaging and diagnostics technologies, including CT scanners and MRI machines Illustrative Illustrative One of the largest pharmaceutical wholesalers in Europe, PHOENIX Group distributes Merative's products in several European countries 40 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

41. 4.2.1 Merative (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Merative and Lilly will collaborate on the development of Merative Diagnostics’ Elecsys Amyloid Plasma Panel Elecsys Amyloid Plasma Panel has demonstrated clinical performance and is currently undergoing additional investigation to ensure clinical validation Once approved, could help healthcare professionals to streamline the journey to diagnosis for more patients ▪ ▪ Collaboration - March, 2023 Lilly ▪ Merative to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 ▪ GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample ▪ Merger $1.8 Bn March 2021 GenMark Diagnostics GenMark’s ePlex platform delivers rapid and actionable results so clinicians can determine the cause of infection and the most effective treatment, potentially saving lives and alleviating the healthcare burden ▪ Illustrative Illustrative 41 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

42. 4.2.1 Merative (continued) Revenues ($Bn), 2020-2030 According to Merative's 2020 financial report, the company had sales of CHF 58.3 Bn (Swiss Francs) in 2020 ▪ This is equivalent to approximately $63.3 Bn USD, based on exchange rates at the end of 2020 ▪ XX Company's Pharmaceuticals Division generated sales of CHF 49.9 Bn in 2020, while the Diagnostics Division generated sales of CHF 8.4 Bn ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2022 Revenue generated by Merative in 2020 reflects the company's continued growth and success in the healthcare industry ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 1 2 3 4 Illustrative Illustrative 42 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

43. 4.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Artificial Intelligence (AI) in Healthcare Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 43 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

44. 4.2.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 44 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

45. 4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 45 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

46. 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 46 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

47. Kenya Artificial Intelligence (AI) in Healthcare Market Analysis 5. Reimbursement Scenario

48. 5.1 Reimbursement Regulation Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Americans The reimbursement scenario in the US Artificial Intelligence (AI) in Healthcare market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: Medicare: o ▪ Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions Medicare covers many Artificial Intelligence (AI) in Healthcare treatments, including chemotherapy, radiation therapy, and some immunotherapies However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization Medicaid: o Medicaid is a joint federal-state program that provides health insurance for people with low incomes o Medicaid coverage for Artificial Intelligence (AI) in Healthcare treatments can vary by state, and may be subject to limits on the amount and type of treatment covered Private Insurance: o Private insurance coverage for Artificial Intelligence (AI) in Healthcare treatments can also vary widely depending on the insurer and the specific policy o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Other Public 1% o Other Private 3% Uninsured 9% Medicare 17% o ▪ Medicaid and CHIP 21% Employer-Sponsored 49% ▪ Health Insurance Coverage, 2022 Illustrative Illustrative 48 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

49. 5.1 Reimbursement Regulation (continued) Affordable Care Act: Affordable Care Act (ACA) includes provisions to help improve access to Artificial Intelligence (AI) in Healthcare treatments by requiring insurers to cover certain preventive services, including Artificial Intelligence (AI) in Healthcare screenings, without co-pays or deductibles It also includes protections for people with pre-existing conditions, such as Artificial Intelligence (AI) in Healthcare Reimbursement for New Treatments: Reimbursement for new Artificial Intelligence (AI) in Healthcare treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage This can create challenges for companies developing and marketing new treatments Value-Based Care: There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics ▪ o o ▪ o o ▪ o o In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative 49 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential

50. 5.1 Reimbursement Regulation (continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure 46.0% xx 47.7% xx xx xx 51.0% 51.8% xx Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid  Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities  Medicaid is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 50 A Sample Report on Kenya Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential